About N-(5-propan-2-yl-1,2-oxazol-4-yl)-2-(1H-pyrrolo[2,3-b]pyridin-3-yl)acetamide
N-(5-propan-2-yl-1,2-oxazol-4-yl)-2-(1H-pyrrolo[2,3-b]pyridin-3-yl)acetamide (PubChem CID 138012535) has the molecular formula C15H16N4O2
and a molecular weight of 284.32 g/mol. Its IUPAC name is N-(5-propan-2-yl-1,2-oxazol-4-yl)-2-(1H-pyrrolo[2,3-b]pyridin-3-yl)acetamide.
Analyze N-(5-propan-2-yl-1,2-oxazol-4-yl)-2-(1H-pyrrolo[2,3-b]pyridin-3-yl)acetamide with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of N-(5-propan-2-yl-1,2-oxazol-4-yl)-2-(1H-pyrrolo[2,3-b]pyridin-3-yl)acetamide?
The IUPAC name of N-(5-propan-2-yl-1,2-oxazol-4-yl)-2-(1H-pyrrolo[2,3-b]pyridin-3-yl)acetamide (CID 138012535) is N-(5-propan-2-yl-1,2-oxazol-4-yl)-2-(1H-pyrrolo[2,3-b]pyridin-3-yl)acetamide.
What is the SMILES notation for N-(5-propan-2-yl-1,2-oxazol-4-yl)-2-(1H-pyrrolo[2,3-b]pyridin-3-yl)acetamide?
The canonical SMILES for N-(5-propan-2-yl-1,2-oxazol-4-yl)-2-(1H-pyrrolo[2,3-b]pyridin-3-yl)acetamide is CC(C)c1oncc1NC(=O)Cc1c[nH]c2ncccc12.
What is the InChIKey of N-(5-propan-2-yl-1,2-oxazol-4-yl)-2-(1H-pyrrolo[2,3-b]pyridin-3-yl)acetamide?
The InChIKey is AKCPRJAZXNAWIX-UHFFFAOYSA-N. The full InChI is InChI=1S/C15H16N4O2/c1-9(2)14-12(8-18-21-14)19-13(20)6-10-7-17-15-11(10)4-3-5-16-15/h3-5,7-9H,6H2,1-2H3,(H,16,17)(H,19,20).
What are the key properties of N-(5-propan-2-yl-1,2-oxazol-4-yl)-2-(1H-pyrrolo[2,3-b]pyridin-3-yl)acetamide?
N-(5-propan-2-yl-1,2-oxazol-4-yl)-2-(1H-pyrrolo[2,3-b]pyridin-3-yl)acetamide has a molecular weight of 284.32 g/mol, XLogP of 2.86, 4 rotatable bonds, 2 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for N-(5-propan-2-yl-1,2-oxazol-4-yl)-2-(1H-pyrrolo[2,3-b]pyridin-3-yl)acetamide is sourced from PubChem (CID 138012535), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).